Transbiohope | News
Transbio project, oriented to the development of an in vitro diagnostic kit for the treatment of chronic rejection with immunosuppressants. H2020 program of the European Union
"trasplante riñón” “diagnóstico in vitro” “in vitro diagnosis” “trasplante renal” “H2020” “European Commission project” “renal transplant” “kidney transplant” “start-up” “Tres Cantos” “biomedicina” “biomedicine” “biotechnology” “immunobiogram” “inmunobiograma” “tratamiento inmunosupresores” “Treatment with immunosuppressants”
62
archive,category,category-news,category-62,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

News

Biohope, an R&D company dedicated to the development of precision medicine IVD tools for chronic inflammatory conditions, announces the completion of the TRANSBIO clinical study. The TRANSBIO clinical study has included nearly 200 patients from 9  international hospitals. Data on patients’ clinical and immunological history has been collected as...

Our CEO Isabel Portero and medical director Teresa Díez are at ATC2019Boston presenting the results of BH-Pilot clinical study which demonstrate the use of Immunobiogram® in the personalization of immunosupresant therapy.  We are proud that our poster have been award-winner. The American Transplant Congress is the...

Isabel Portero, CEO of Biohope, participates in this invitation-only event organized by The European Innovation Council (EIC). EIC  supports top-class innovators, entrepreneurs, small companies and scientists with bright ideas and the ambition to scale up internationally. It brings together the parts of Horizon 2020 that provide...